Yaƙin Wu: Shan wahala daga myeloma mai yawa

An gano cewa Patient Wu, namiji mai shekaru 71, yana da cutar multiple myeloma.

Ya nemi magani a Bioocus International Medical Center a shekarar 2022 kuma ya gamsu sosai da kulawarsa. Binciken farko ya nuna cewa an gano MRI da T5T scan a lumbar, ciki har da karaya ta mazugi T10, T11, da L1 tare da kumburin mazugi. Bugu da ƙari, an ga ƙananan sigina marasa kyau a jikin vertebral na L2. Binciken biopsy na vertebral ya tabbatar da myeloma na ƙwayoyin plasma. Ƙarin gwaje-gwaje sun nuna plasma na prokaryotic wanda ya ƙunshi kashi 46% na biopsy na mazugi na ƙashi, tare da ƙwayoyin da aka ɗora marasa kyau waɗanda suka ƙunshi kashi 14% a cikin cytometry na kwarara. Biopsy na haɗin ƙashi ya nuna kashi 70% na problastoma. Binciken FISH ya nuna asarar kwayoyin halitta a cikin lq21 (CKSIB) da 1m32 (CDKN2C), yayin da gwajin FTSH ya nuna cewa an goge kwayoyin halitta na p53, kuma ICH ya kasance mara kyau a gwajin FISH. Ganowar ƙarshe ita ce follipoma mai yawa na osteoblastic (nau'in sarkar haske ta L), tare da DS a cikin rukunin B, ISS staging III, da RISS stage a Mataki na II. Patient Wu ya nuna godiya ga cikakkiyar magani da cibiyar lafiya ta bayar.

Tarihin magani na baya:

Alamomin asibiti na myeloma da yawa suna da bambanci, galibi sun haɗa da rashin jini, ciwon ƙashi, rashin isasshen koda, kamuwa da cuta, zubar jini, alamun jijiyoyi, hypercalcemia, da kuma bayan gida amyloid. Asibitin ya gudanar da maganin hana kamuwa da cuta mai tsanani tare da gyara rashin jini da ƙarancin platelets. Kimanin watanni 2 bayan shigar ƙwayoyin BCMA CAR-T, alamun majinyacin sun koma daidai a hankali, kuma yanayinsa yana ƙarƙashin kulawa. Cibiyar Kiwon Lafiya ta Bioocus ta ci gaba da sa ido kan majinyacin don tabbatar da dorewar tasirin magani.